Search

Author/Creator Curigliano, G

2. 1452PCombination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation. (23rd October 2018)

Authors:
Viteri, S; Chang, G-C; Chiari, R; Cho, B C; Ciardiello, F; Curigliano, G; Hida, T; Lee, D H; Lim, W T D; Lin, C-C; Martinez, A; Murakami, H; Natsume, I; Nishio, M; Paz-Ares, L; Soo, R A; Cattan, V; Gandossi, E; Heck, H; Park, K
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1692PPhysicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey. (23rd October 2018)

Authors:
Lambertini, M; Di Maio, M; Poggio, F; Pagani, O; Curigliano, G; Del Mastro, L; Paluch-Shimon, S; Loibl, S; Partridge, A H; Azim, H A; Peccatori, F A; Demeestere, I
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 289PDLucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial. (23rd October 2018)

Authors:
Hui, R; Pearson, A; Cortes Castan, J; Campbell, C; Poirot, C; Azim, H A; Fumagalli, D; Lambertini, M; Daly, F; Arahmani, A; Perez-Garcia, J; Aftimos, P G; Bedard, P; Xuereb, L; Loibl, S; Loi, S; Pierrat, M-J; Turner, N C; André, F; Curigliano, G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 363OTreatment with pralsetinib (formerly BLU-667), a potent and selective RET inhibitor, provides rapid clearance of ctDNA in patients with RET-altered non-small cell lung cancer (NSCLC) and medullary thyroid cancer (MTC). (24th November 2019)

Authors:
Lee, D H; Subbiah, V; Gainor, J F; Taylor, M H; Zhu, V W; Doebele, R C; Lopes, G; Baik, C; Garralda, E; Gadgeel, S M; Kim, D-W; Turner, C D; Palmer, M; Miller, S; Curigliano, G
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer. (25th October 2017)

Authors:
Criscitiello, C; Bayar, M A; Curigliano, G; Symmans, F W; Desmedt, C; Bonnefoi, H; Sinn, B; Pruneri, G; Vicier, C; Pierga, J Y; Denkert, C; Loibl, S; Sotiriou, C; Michiels, S; André, F
Journal:
Annals of oncology
Issue:
Volume 29:Number 1(2018)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (3rd May 2018)

Authors:
Curigliano, G; Burstein, H J; Winer, E P; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, M M; Piccart-Gebhart, M; Senn, H -J; Thürlimann, B; André, F; Baselga, J; Bergh, J; Bonnefoi, H; Brucker, S Y; Cardoso, F; Carey, L; Ciruelos, E; Cuzick, J
Journal:
Annals of oncology
Issue:
Volume 29:Number 10(2018)
Page Start:
2153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗